Originally Aired: July 23, 2020
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Cell therapies such as CAR-T have revolutionized the biopharmaceutical industry, especially manufacturing processes. As a result, cell therapy developers are always searching for flexible solutions to aid their production workflows. Automating several steps in the manufacturing process can not only increase efficiency but also create a more consistent and efficacious product. Additionally, because cell therapy production requires special environments, fill and finish operations present a unique set of challenges.
In this GEN webinar, we will hear from a team of scientists who will discuss the parameters for the fill/finish and cryopreservation steps of a cell therapy manufacturing process. We will also look at data from a typical manual fill and finish process compared to data from an automated process using the Finia® Fill and Finish System.
A live Q&A session followed the presentations, offering a chance to pose questions to our expert panelists.
Produced with support from: